Takumi Habu

National Cancer Center Hospital East

Papers

4

Total Citations

62

H-Index

4

About

Takumi Habu is a leading figure in the advancement of minimally invasive surgery for gastric cancer, with a focused expertise in robotic gastrectomy. His research systematically demonstrates the clinical advantages of robotic over conventional laparoscopic techniques, particularly in reducing postoperative complications. In a pivotal 2021 case-control study (41 citations), Habu established that robotic surgery significantly lowers complication rates, setting a new benchmark for surgical safety. He has further refined this work by showing that robotic gastrectomy offers superior outcomes for overweight patients (2023, 6 citations) and that it is a feasible, effective alternative to open surgery for challenging Borrmann type 4 gastric cancers (2024, 5 citations). Through his single-center retrospective cohort study in a Japanese high-volume center (2024, 10 citations), Habu provides robust, real-world evidence supporting the adoption of robotic total gastrectomy. His cumulative work, which has garnered over 60 citations, is instrumental in defining the role of robotic surgery as a safer, more precise option for complex gastric cancer cases, directly influencing surgical practice and patient recovery standards.

Research Focus

Key Achievements

4
H-Index
4
Papers
62
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Reduction in postoperative complications by robotic surgery: a case–control study of robotic versus conventional laparoscopic surgery for gastric cancer
41 citations · 2021
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: National Cancer Center Hospital East

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago